Greenwich LifeSciences (GLSI) Metrics: History & Chart

Greenwich LifeSciences, Inc.(GLSI)

Biotechnology · Stafford, TX

$16.55-0.36 (-2.13%)

Delayed quote: Oct 6, 2026, 12:09 PM EDT

About Greenwich LifeSciences, Inc.

Greenwich LifeSciences, Inc. functions as a clinical-stage biopharmaceutical company, dedicated to developing innovative cancer immunotherapies. These treatments are primarily focused on breast cancer and other HER2/neu-positive malignancies. Its flagship therapeutic candidate is GP2, an immunotherapy which has successfully completed its Phase IIb clinical trials. This drug is designed to prevent the recurrence of breast cancer in patients who have already undergone surgical removal of the tumor. Founded in 2006 and based in Stafford, Texas, the company was formerly known as Norwell, Inc. until it rebranded to Greenwich LifeSciences, Inc. in March 2018.

Stafford, TX

13 employees

greenwichlifesciences.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Snehal S. Patel

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	-9.04%
30D Total Return	+6.02%
YTD Total Return	-19.51%
1Y Total Return	+55.00%
3Y Total Return	+98.69%
5Y Total Return	-55.21%
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	-19.51%
2025	+87.09%
2024	+6.75%
2023	-30.79%
2022	-37.53%
2021	-33.29%
2020

CAGR TTM	+54.67%
CAGR 3Y	+25.71%
CAGR 5Y	-14.84%
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	N/A
PE Ratio Avg TTM	N/A
PE Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

All Metrics

GLSI Valuation Metrics

GLSI Stock Price Metrics

GLSI Dividend Metrics

GLSI Growth Rate Metrics

GLSI Discounted Cash Flow Metrics

GLSI Returns By Period

GLSI Yearly Returns

GLSI Average Annual Returns By Period (CAGR)

GLSI Revenue Metrics

GLSI PE Ratio Metrics

GLSI PS Ratio Metrics

GLSI PB Ratio Metrics

GLSI Price to Free Cash Flow Ratio Metrics

GLSI Debt to Equity Ratio Metrics

GLSI PEG Ratio Metrics

GLSI FCF Yield

GLSI Earnings Yield

GLSI EBITDA Yield

GLSI OCF Yield

GLSI EV/EBIT Ratio Metrics

GLSI EV/EBITDA Ratio Metrics

GLSI EV/Assets Ratio Metrics

GLSI EV/Sales Ratio Metrics

GLSI Current Ratio Metrics

GLSI Quick Ratio Metrics

GLSI ROIC Metrics

GLSI Return on Assets Metrics

GLSI Return on Equity Metrics

GLSI Net Profit Margin Metrics

GLSI Gross Profit Margin Metrics

GLSI Tax Rate Metrics

PS Ratio	N/A
PS Ratio Avg TTM	N/A
PS Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

PB Ratio	79.32
PB Ratio Avg TTM	107.77
PB Ratio Avg 3Y	63.55
Current VS TTM Avg	-26.40%
Current VS 3Y Avg	+24.81%
Current VS 5Y Avg	+153.02%

PFCF Ratio	N/A
PFCF Ratio Avg TTM	N/A
PFCF Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Debt/Equity Ratio	0.00
Debt/Equity Ratio Avg TTM	0.00
Debt/Equity Ratio Avg 3Y	0.00
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	N/A
FCF Yield Avg TTM	N/A
FCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	N/A
Earnings Yield Avg TTM	N/A
Earnings Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	26.85
Ev/Assets Ratio Avg TTM	56.21
Ev/Assets Ratio Avg 3Y	28.81
Current VS TTM Avg	-52.24%
Current VS 3Y Avg	-6.82%
Current VS 5Y Avg	+34.62%

Ev/Sales Ratio	N/A
Ev/Sales Ratio Avg TTM	N/A
Ev/Sales Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Current Ratio	1.54
Current Ratio Avg TTM	1.76
Current Ratio Avg 3Y	7.85
Current VS TTM Avg	-12.53%
Current VS 3Y Avg	-80.37%
Current VS 5Y Avg	-94.90%

Quick Ratio	1.54
Quick Ratio Avg TTM	1.76
Quick Ratio Avg 3Y	7.85
Current VS TTM Avg	-12.53%
Current VS 3Y Avg	-80.37%
Current VS 5Y Avg	-94.90%

ROIC	(701.55%)
ROIC Avg 3Y	(499.97%)
ROIC Avg 5Y	(314.24%)
Current VS 3Y Avg	-40.32%
Current VS 5Y Avg	-123.25%
Current VS 10Y Avg	-282.03%

ROA	(244.25%)
ROA Avg TTM	(92.89%)
ROA Avg 3Y	(74.44%)
Current VS TTM Avg	-162.95%
Current VS 3Y Avg	-228.14%
Current VS 5Y Avg	-637.61%

ROE	(695.56%)
ROE Avg TTM	(658.74%)
ROE Avg 3Y	(348.12%)
Current VS TTM Avg	-5.59%
Current VS 3Y Avg	-99.81%
Current VS 5Y Avg	-562.88%

Net Profit Margin	0.00%
Net Profit Margin Avg TTM	0.00%
Net Profit Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Gross Profit Margin	0.00%
Gross Pft Margin Avg TTM	0.00%
Gross Pft Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Tax Rate	0.00%
Tax Rate Avg 3Y	0.00%
Tax Rate Avg 5Y	0.00%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	N/A